Evidence map›Paper›PMID 37789462›Full record

ArticleParasites & vectors2023

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola.

Begoña Febrer-Sendra, Beatriz Crego-Vicente, Arlette Nindia, Joan Martínez-Campreciós, Sandra Aixut, Alejandro Mediavilla, Aroa Silgado, Inés Oliveira-Souto, Fernando Salvador, Israel Molina and 3 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Begoña Febrer-SendraInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Salamanca, Spain.
Beatriz Crego-VicenteInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Salamanca, Spain.
Arlette NindiaHospital Nossa Senhora da Paz, Cubal, Angola.
Joan Martínez-CampreciósHospital Nossa Senhora da Paz, Cubal, Angola.
Sandra AixutHospital Nossa Senhora da Paz, Cubal, Angola.
Alejandro MediavillaMicrobiology Department Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Aroa SilgadoMicrobiology Department Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Inés Oliveira-SoutoCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Fernando SalvadorCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Israel MolinaCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Antonio MuroInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Salamanca, Spain.
Elena SulleiroMicrobiology Department Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain. elena.sulleiro@vallhebron.cat.
Pedro Fernández-SotoInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Salamanca, Spain. pfsoto@usal.es.
Instituto de Investigación Biomédica de Salamanca · ESVall d'Hebron Hospital Universitari · ESInstituto de Salud Carlos III · ESCentro de Investigación Biomédica en Red · ES

Funding

Instituto de Salud Carlos III PI22/01721Junta de Castilla y León 422058Junta de Castilla y León 487971
6 · The paper itself

Abstract

backgroundMalaria is a globally distributed infectious disease. According to the World Health Organization, Angola is one of the six countries that account for over half the global malaria burden in terms of both malaria cases and deaths. Diagnosis of malaria still depends on microscopic examination of thin and thick blood smears and rapid diagnostic tests (RDTs), which often lack analytical and clinical sensitivity. Molecular methods could overcome these disadvantages. The aim of this study was to evaluate, for the first time to our knowledge, the performance of a loop-mediated isothermal amplification (LAMP) for the diagnosis of malaria in an endemic area in Cubal, Angola, and to assess the reproducibility at a reference laboratory.

methodsA total of 200 blood samples from patients attended at Hospital Nossa Senhora da Paz, Cubal, Angola, were analysed for Plasmodium spp. detection by microscopy, RDTs, and LAMP. LAMP assay was easily performed in a portable heating block, and the results were visualized by a simple colour change. Subsequently, the samples were sent to a reference laboratory in Spain to be reanalysed by the same colorimetric LAMP assay and also in real-time LAMP format.

resultsIn field tests, a total of 67/200 (33.5%) blood samples were microscopy-positive for Plasmodium spp., 98/200 RDT positive, and 112/200 (56%) LAMP positive. Using microscopy as reference standard, field LAMP detected more microscopy-positive samples than RDTs (66/67; 98% vs. 62/67; 92.5%). When samples were reanalysed at a reference laboratory in Spain using both colorimetric and real-time assays, the overall reproducibility achieved 84.5%.

conclusionsThis is the first study to our knowledge in which LAMP has been clinically evaluated on blood samples in a resource-poor malaria-endemic area. The colorimetric LAMP proved to be more sensitive than microscopy and RDTs for malaria diagnosis in field conditions. Furthermore, LAMP showed an acceptable level of reproducibility in a reference laboratory. The possibility to use LAMP in a real-time format in a portable device reinforces the reliability of the assay for molecular diagnosis of malaria in resource-poor laboratories in endemic areas.

Indexed as

MalariaMalaria, FalciparumPlasmodiumAngolaHumansLaboratoriesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesReproducibility of ResultsSensitivity and SpecificityAngolaField conditionsLoop-mediated isothermal amplification (LAMP)MalariaPlasmodium spp.Point of care (POC)

Identifiers

PMID37789462
PMCPMC10548721
OpenAlexW4387301289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.